94 related articles for article (PubMed ID: 35038209)
21. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS; Smeland S; Whelan JS; Marina N; Jovic G; Hook JM; Krailo MD; Gebhardt M; Pápai Z; Meyer J; Nadel H; Randall RL; Deffenbaugh C; Nagarajan R; Brennan B; Letson GD; Teot LA; Goorin A; Baumhoer D; Kager L; Werner M; Lau CC; Sundby Hall K; Gelderblom H; Meyers P; Gorlick R; Windhager R; Helmke K; Eriksson M; Hoogerbrugge PM; Schomberg P; Tunn PU; Kühne T; Jürgens H; van den Berg H; Böhling T; Picton S; Renard M; Reichardt P; Gerss J; Butterfass-Bahloul T; Morris C; Hogendoorn PC; Seddon B; Calaminus G; Michelagnoli M; Dhooge C; Sydes MR; Bernstein M;
J Clin Oncol; 2015 Jul; 33(20):2279-87. PubMed ID: 26033801
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
23. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
24. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
25. Pediatric Osteosarcoma of Extremities: A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt.
Morsy AM; Abdelgawad MI; Ahmed BM; Rezk KM; Aboelgheit AM; Ramadan IK; Kamel HEM; Fouad DM; Herdan RA; Shabaan SH; Eltyb HA
J Pediatr Hematol Oncol; 2019 Aug; 41(6):e371-e383. PubMed ID: 30629005
[TBL] [Abstract][Full Text] [Related]
26. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
27. [The analysis of failures in therapy of osteosarcoma in children treated according to SFOP-94 protocol in the studies of Polish pediatric solid tumors treatment group].
Chybicka A; Jaworski W; Liebhart M; Gołebiowski W; Kazanowska B; Wecławek-Tompol J; Woźniak W; Kowalczyk J; Katski K; Kołecki P; Boruczkowski D; Leda M
Wiad Lek; 1998; 51 Suppl 4():40-4. PubMed ID: 10731942
[TBL] [Abstract][Full Text] [Related]
28. Curative-intent radiotherapy for pediatric osteosarcoma: The St. Jude experience.
Tinkle CL; Lu J; Han Y; Li Y; McCarville BM; Neel MD; Bishop MW; Krasin MJ
Pediatr Blood Cancer; 2019 Aug; 66(8):e27763. PubMed ID: 31012273
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
30. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
Lee JA; Kim MS; Kim DH; Lim JS; Yoo JY; Koh JS; Lee SY; Jeon DG; Park KD
Pediatr Blood Cancer; 2008 Feb; 50(2):195-200. PubMed ID: 18061933
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
[TBL] [Abstract][Full Text] [Related]
32. The magnitude and predictors of therapy abandonment in pediatric central nervous system tumors in low- and middle-income countries: Systematic review and meta-analysis.
Seah T; Zhang C; Halbert J; Prabha S; Gupta S
Pediatr Blood Cancer; 2019 Jun; 66(6):e27692. PubMed ID: 30835958
[TBL] [Abstract][Full Text] [Related]
33. A Retrospective Comparative Analysis of Outcomes and Prognostic Factors in Adult and Pediatric Patients with Osteosarcoma.
Testa S; Hu BD; Saadeh NL; Pribnow A; Spunt SL; Charville GW; Bui NQ; Ganjoo KN
Curr Oncol; 2021 Dec; 28(6):5304-5317. PubMed ID: 34940082
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
35. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
[TBL] [Abstract][Full Text] [Related]
36. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
37. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
[TBL] [Abstract][Full Text] [Related]
38. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience.
Leary SE; Wozniak AW; Billups CA; Wu J; McPherson V; Neel MD; Rao BN; Daw NC
Cancer; 2013 Jul; 119(14):2645-53. PubMed ID: 23625626
[TBL] [Abstract][Full Text] [Related]
39. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
40. Treatment abandonment and refusal among children with central nervous system tumors in Jordan.
Amayiri N; Bouffet E
Pediatr Blood Cancer; 2021 Aug; 68(8):e29054. PubMed ID: 34022111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
